The Editor-in-Chief is retracting this article  because of overlap with other published articles, most significantly with [2–4]. Jianing Fu and Ning Zhang agree with this retraction. Weihua Lou, Fang Ji, Zhiqiang Han and Wen Di have not responded to correspondence about this retraction.
1. Lou W, Ji F, Fu J, Han Z, Di W, Zhang N. Transcriptional retargeting of herpes simplex virus for cell-specific replication to control cancer. J Cancer Res Clin Oncol (2018). https://doi.org/10.1007/s00432-017-2566-4
2. Mullen JT, Kasuya H, Yoon SS, Carroll NM, Pawlik TM, Chandrasekhar S, Nakamura H, Donahue JM, Tanabe KK. Regulation of herpes simplex virus 1 replication using tumor-associated promoters. Ann Surg. 2002;236:502–512
3. Kasuya H, Pawlik TM, Mullen JT, Donahue JM, Nakamura H, Chandrasekhar S, et al. Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen. Cancer Res. 2004;64:2561–7
4. Yamamura H, Hashio M, Noguchi M, Sugenoya Y, Osakada M, Hirano N, Sasaki Y, Yoden T, Awata N, Araki N, Tatsuta M, Miyatake SI, Takahashi K. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors. Cancer Res. 2001;61:3969–77